Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide. According to our (Global Info Research) latest study, the global Nuclear Medicine market size was valued at USD 6368.4 million in 2022 and is forecast to a readjusted size of USD 10280 million by 2029 with a CAGR of 7.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second place consumption region with the consumption market share of about 25%. Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share. The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%. Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%. This report is a detailed and comprehensive analysis for global Nuclear Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Nuclear Medicine market size and forecasts, in consumption value ($ Million), 2018-2029 Global Nuclear Medicine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029 Global Nuclear Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029 Global Nuclear Medicine market shares of main players, in revenue ($ Million), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Nuclear Medicine To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Nuclear Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging and Bayer, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market segmentation Nuclear Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Tc-99 I-123/131 In-111 Xe-133 Th-201 Ga-67 Others Market segment by Application Diagnostic Therapeutic Market segment by players, this report covers GE Healthcare Bracco Imaging Mallinckrodt Lantheus Medical Imaging Bayer Triad Isotopes Nordion Jubilant Pharma Eli Lilly SIEMENS China Isotope & Radiation Dongcheng Market segment by regions, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific) South America (Brazil, Argentina and Rest of South America) Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa) The content of the study subjects, includes a total of 13 chapters: Chapter 1, to describe Nuclear Medicine product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top players of Nuclear Medicine, with revenue, gross margin and global market share of Nuclear Medicine from 2018 to 2023. Chapter 3, the Nuclear Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast. Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029. Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nuclear Medicine market forecast, by regions, type and application, with consumption value, from 2024 to 2029. Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War Chapter 12, the key raw materials and key suppliers, and industry chain of Nuclear Medicine. Chapter 13, to describe Nuclear Medicine research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Nuclear Medicine 1.2 Market Estimation Caveats and Base Year 1.3 Classification of Nuclear Medicine by Type 1.3.1 Overview: Global Nuclear Medicine Market Size by Type: 2018 Versus 2022 Versus 2029 1.3.2 Global Nuclear Medicine Consumption Value Market Share by Type in 2022 1.3.3 Tc-99 1.3.4 I-123/131
